China Medical System Holdings Ltd (CMS; HKG: 0867) announced its proposal for a secondary listing on the Main Board of the Singapore Exchange Securities Trading Limited (SGX) via introduction. The company’s shares will continue to maintain their primary listing and trading status on The Stock Exchange of Hong Kong Limited.
Listing Purpose
The secondary listing is designed to broaden shareholder base, enhance share liquidity, and increase visibility in international capital markets. It will also provide greater flexibility for future global business expansion and potential financing activities.
Regulatory Process
CMS has made the listing filing to SGX and received the overseas listing filing acknowledgment letter from the China Securities Regulatory Commission (CSRC) on the same day. However, the company has not yet obtained SGX’s eligibility-to-list letter, and the secondary listing is subject to relevant regulatory approvals.-Fineline Info & Tech
